-
Mashup Score: 32Comprehensive Genomic Profiling Improves Precision Therapy Use and Patient Survival - 1 month(s) ago
Two-thirds of patients with advanced cancer whose biopsies were tested using an in-house comprehensive genomic profiling assay were found to be candidates for precision therapies, according to a study at a large U.S. health system. The study also found a survival advantage among patients who received targeted therapies versus those who received chemotherapy alone.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 28Comprehensive Genomic Profiling Improves Precision Therapy Use and Patient Survival - 1 month(s) ago
Two-thirds of patients with advanced cancer whose biopsies were tested using an in-house comprehensive genomic profiling assay were found to be candidates for precision therapies, according to a study at a large U.S. health system. The study also found a survival advantage among patients who received targeted therapies versus those who received chemotherapy alone.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
Comprehensive Genomic Profiling Improves Precision Therapy Use and Patient Survival https://t.co/AjCFIQQ2bC @asco
-
-
Mashup Score: 26Comprehensive Genomic Profiling Improves Precision Therapy Use and Patient Survival - 1 month(s) ago
Two-thirds of patients with advanced cancer whose biopsies were tested using an in-house comprehensive genomic profiling assay were found to be candidates for precision therapies, according to a study at a large U.S. health system. The study also found a survival advantage among patients who received targeted therapies versus those who received chemotherapy alone.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
Comprehensive Genomic Profiling Improves Precision Therapy Use and Patient Survival https://t.co/AjCFIQQ2bC @asco
-
-
Mashup Score: 26Comprehensive Genomic Profiling Improves Precision Therapy Use and Patient Survival - 1 month(s) ago
Two-thirds of patients with advanced cancer whose biopsies were tested using an in-house comprehensive genomic profiling assay were found to be candidates for precision therapies, according to a study at a large U.S. health system. The study also found a survival advantage among patients who received targeted therapies versus those who received chemotherapy alone.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
Comprehensive Genomic Profiling Improves Precision Therapy Use and Patient Survival https://t.co/AjCFIQQ2bC @asco
-
-
Mashup Score: 33Education Scholars Program - 2 month(s) ago
An overview of the Leadership Development Program: Education Scholars timeline and curriculum for the upcoming application cycle, including eligibility criteria for prospective applicants.
Source: society.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Apply now for the @asco Education Scholars Program - applications due Novemebr 18th. https://t.co/pEUAkyXAkO
-
-
Mashup Score: 33Education Scholars Program - 2 month(s) ago
An overview of the Leadership Development Program: Education Scholars timeline and curriculum for the upcoming application cycle, including eligibility criteria for prospective applicants.
Source: society.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Apply now for the @asco Education Scholars Program - applications due Novemebr 18th. https://t.co/pEUAkyXAkO
-
-
Mashup Score: 20Increasing Access to High-Quality Cancer Care in Rural Communities - 2 month(s) ago
A hub-and-spoke care delivery team is effectively bridging the gap in needs and services for patients with cancer in Montana.
Source: connection.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Read more about @ASCO’s Montana hub-and-spoke rural access cancer care delivery pilot between Barrett Hospital and Bozeman Health here: https://t.co/W6W5DKFGA6
-
-
Mashup Score: 4Fact Sheet: HHS Continues Taking Action to Increase Access and Supply of IV Fluids Following Hurricane Helene - 2 month(s) ago
Fact Sheet: HHS Continues Taking Action to Increase Access and Supply of IV Fluids Following Hurricane Helene
Source: www.hhs.govCategories: General Medicine News, Hem/OncsTweet-
Latest press release from @HHSGov on the IV fluid shortage. -Hospitals have 50% more product available now compared to right after the hurricane. -First airlift of @baxter_intl products into US from international facilities scheduled for October 19. https://t.co/LWF9ahD9P9
-
-
Mashup Score: 32Education Scholars Program - 2 month(s) ago
An overview of the Leadership Development Program: Education Scholars timeline and curriculum for the upcoming application cycle, including eligibility criteria for prospective applicants.
Source: society.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Apply now for the @asco Education Scholars Program - applications due Novemebr 18th. https://t.co/pEUAkyXAkO
-
-
Mashup Score: 13Tobacco Product Use Among Middle and High School ... - 2 month(s) ago
This report describes use of any tobacco product among middle and high school students from 2023 to 2024.or ADHD services.
Source: www.cdc.govCategories: General Medicine News, Hem/OncsTweet-
Tobacco Product Use Among US Pre-Teens, Teens Has Dropped To Lowest Levels Seen In 25 Years @CDCgov https://t.co/VcZfjfUYf5
-
Comprehensive Genomic Profiling Improves Precision Therapy Use and Patient Survival https://t.co/AjCFIQQ2bC @asco